中药静脉制剂治疗急性脑梗死的疗效观察  

Effect of Chinese medicine intravenous preparation in the treatment of acute cerebral infarction

作　　者：黄小萍 吴涛 陆耀军 Huang Xiaoping;Wu Tao;Lu Yaojun(The Fifth Clinieal Hospital Affiliated to Yangzhou University,the Second People＇s Hospital of Changshu City 215500)

机构地区：[1]江苏省扬州大学附属第五临床医院,常熟市第二人民医院,215500

出　　处：《中国社区医师》2018年第33期97-98,共2页Chinese Community Doctors

摘　　要：目的:探讨中药静脉制剂治疗急性脑梗死的疗效。方法:收治急性期脑梗死患者246例,分为对照组和中药组,每组123例。对照组采用常规治疗,中药组在对照组基础上加用中药静脉制剂治疗,比较两组治疗效果。结果:治疗后,两组NIHSS评分比较差异无统计学意义(P>0.05)。结论:中药静脉制剂与传统治疗方法并没有明显优势,仅在SAA亚组中有一定优势,提示我们在临床实践中,根据TOAST型来合理选择中药静脉制剂可能更加科学,也能节约有限医药资源。Objective：Key words To explore the effect of Chinese medicine intravenous preparation in the treatment of acute cerebral infaretion.Methods：246 patients with acute cerebral infarction were selected,they were divided into the control group and the Chinese medicine group.The control group was treated with routine treatment,the Chinese medicine group was treated with Chinese medicine intravenous preparation on the basis of the control group,we compared the therapeutic effects of the two groups. Results：After treatment,there was no significant difference in NIHSS score between the two groups（P〉 0.05）.Conclusion： Compared with traditional treatment,Chinese medicine intravenous preparation had no obvious advantage,it had certain advantages only in the SAA subgroup,it was suggested that the rational selection of intravenous preparations based on TOAST may be more scientific and save limited medical resources in clinical practice.

关 键 词：中药静脉制剂 急性脑梗死 疗效 

分 类 号：R277.7[医药卫生—中医学]